The ketogenic and the modified Atkins diets, high in fat and low in carbohydrates, could reduce these seizures, suggesting that clinicians bring them into the treatment discussion.
Nervous System Diseases
The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.
These findings advance knowledge about the link between brain inflammation and the progression of brain disorders and suggest possible targets for future treatments.
Approved for patients with relapsing forms of MS, the drug generally should be reserved for those who have had an inadequate response to 2 or more drugs indicated for MS treatment.
Up until now, these treatments have not produced promising efficacy results in clinical trials. MRI could show the way.
As more treatments become available, patients will have more preferences and will play a more prominent role in directing choices.
Some very recent research findings have added to the literature on the associations between migraine and depression, anxiety, and other disorders. Highlights here.
Determining who is at risk for MS remains difficult, and symptoms may take time to develop even in patients who already have some destroyed myelin. MRI may help.
Here: 5 new things to know about stroke -- its link with perioperative A-fib; the danger of cocaine; rehab possibilities with an Alzheimer drug; reducing stroke risk with potassium; and a potential screen for occult A-fib after cryptogenic stroke.
Previously, the football sideline was the sole domain of orthopedic surgeons and athletic trainers. Neurologists are now part of a growing team of physicians with an interest in treating athletes.